PubMed · 2000 · 25 citations · 0 references
Life SciencesGeneticsOncologyCancer GeneticsGenetic EpidemiologyMedical GeneticsCancer RiskGenetic RiskGenetic Risk AssessmentGenetic Risk FactorsGenetic SusceptibilityMolecular Risk FactorsCancer Risk AssociationCytochrome EnzymesCytochrome P450 Genetic PolymorphismCytochrome P450 Genotype EffectsGenetic Predisposition To CancerLung Cancer RiskRestriction Fragment Length Polymorphism AnalysisSmoking-related Genetic Risk
OBJECTIVE: To investigate the genetic polymorphism of cytochrome P4502E1 (CYP2E1) as a susceptibility factor for lung cancer in Chinese population. METHODS: The genotype frequencies of RsaI restriction fragment length polymorphisms were analyzed in 92 lung cancer cases and 137 frequency-matched normal controls. RESULTS: The CYP2E1 c1/c1 genotype was found in 72.8% of lung cancer cases, which was significantly higher (P < 0.01) than that in controls (54.7%). By multivariate analysis, this genotype was found to be associated with a 2.5-fold increased risk of lung cancer (adjusted OR 2.5, 95% CI 1.8-3.8). Stratified analysis suggested an interaction between CYP2E1 c1/c1 genotype and cigarette smoking. The odds ratio (OR) for the CYP2E1 c1/c1 genotype, cigarette smoking and both factors combined was 3.9 (95% CI 1.1-15.2), 4.1 (95% CI 1.1-15.9) and 7.9 (95% CI 2.4-29.4), respectively. The interaction between CYP2E1 c1/c1 genotype and pack-years of cigarette smoking followed the same pattern, with a markedly increased risk in the heaviest smokers. CONCLUSION: The CYP2E1 c1/c1 genotype is a susceptibility factor for development of lung cancer in Chinese and there is an apparent gene-environment interaction between the susceptible genotype and cigarette smoking.